Thorne's New Studies: The Science of Selling Wellness

SUMMERVILLE, S.C. – March 09, 2026 – In a move designed to fortify its position as a leader in evidence-based health products, wellness company Thorne today announced compelling results from two new consumer studies for its popular Magnesium Glycinate and Ginseng Plus supplements. The findings, which report significant user-perceived improvements in sleep, stress, and energy, underscore a key strategic battleground in the multi-billion dollar supplement industry: the quest for scientific validation.

As consumers grow more sophisticated and skeptical, the pressure is mounting on brands to provide more than just a list of ingredients. Thorne's announcement highlights its strategy of investing in research to substantiate its product claims, aiming to build consumer trust in a market often criticized for a lack of transparency and regulatory oversight.

The Impressive Numbers

According to the company's press release, the results from the structured, open-label consumer perception trials were overwhelmingly positive.

In a 28-day study involving 95 participants, Thorne's Magnesium Glycinate formula was linked to substantial wellness benefits. An impressive 91% of users reported an improvement in their sleep, while 94% felt they had an improved ability to remain calm during stressful situations. Furthermore, 84% noted improvements in overall stress levels, mood, or focus, and 76% experienced better muscle relaxation or recovery. The positive sentiment was widespread, with 93% of participants reporting a positive overall experience with the product.

Similarly, a separate 30-day study of 89 healthy adults experiencing low energy and high stress levels found rapid benefits from Thorne's Ginseng Plus. A significant 85% of participants reported improved energy levels. The formula also appeared to address the mental side of stress, with 72% reporting reduced perceived stress and enhanced mental clarity, and 71% noting an improved mood. The product's reception was strong, with 91% of users stating they would recommend it.

"These studies exemplify our unwavering commitment to developing wellness solutions grounded in rigorous science and substantiated by evidence-based outcomes in our finished formulations," said Ken Rowe, Chief R&D Officer at Thorne. "Today's consumers expect transparency, integrity, and results. At Thorne, those principles are embedded in our decades of research, clinical partnerships, and scientific leadership."

Perception vs. Proof: Understanding the Studies

While the percentages are striking, it is crucial to understand the nature of the research. Thorne's studies were conducted as "structured, open-label consumer perception trials." This methodology, while valuable, differs significantly from the gold standard of medical research: the double-blind, placebo-controlled clinical trial.

In an open-label study, participants know they are taking the active supplement. This design is excellent for gathering real-world feedback on user experience, satisfaction, and perceived benefits. However, it cannot eliminate the powerful influence of the placebo effect—the well-documented phenomenon where a person's belief in a treatment can cause a perceived or real improvement in their condition. Without a control group taking a placebo, it is scientifically difficult to isolate the supplement's direct physiological effects from the psychological impact of taking it.

These studies are not designed to prove clinical efficacy in the way the FDA requires for pharmaceutical drugs. Instead, they serve to substantiate what are known as "structure/function claims," which describe a supplement's role in affecting the normal structure or function of the body (e.g., "supports restful sleep"). The data provides a company with a defensible basis for its marketing claims, aligning with FTC guidelines that require advertising to be truthful and substantiated by competent evidence.

Grounded in Science: Do the Claims Hold Up?

Despite the methodological limitations for proving efficacy, Thorne’s findings are not occurring in a scientific vacuum. The reported benefits for both Magnesium Glycinate and Ginseng Plus align closely with a substantial body of existing research on their core ingredients.

Magnesium is a critical mineral involved in over 300 enzymatic reactions in the body. Its role in the nervous system is well-established; it helps regulate neurotransmitters like GABA that promote relaxation and plays a part in controlling the body's stress-response system. Magnesium glycinate, the form used by Thorne, is a chelated version bound to the amino acid glycine. This form is known for its high bioavailability and gentle effect on the digestive system. Glycine itself has been shown in studies to improve sleep quality, potentially providing a synergistic benefit.

Likewise, ginseng is one of the most extensively researched herbs in botanical medicine. As a premier adaptogen, it is known to help the body build resilience and adapt to physical and mental stressors. Its active compounds, ginsenosides, have been shown to modulate the hypothalamic-pituitary-adrenal (HPA) axis—the body's central stress control center. This action can help regulate cortisol levels, combat fatigue, and enhance cognitive functions like mental clarity and focus. The results from Thorne’s Ginseng Plus study, therefore, are biologically plausible and consistent with ginseng's known adaptogenic properties.

The Business of Belief: A Strategy for Market Leadership

In the fiercely competitive supplement market, Thorne's investment in consumer research is a calculated strategic move. By generating proprietary data on its finished products, the company differentiates itself from the myriad of brands that rely solely on generic, third-party research about individual ingredients. This approach allows Thorne to build a narrative of evidence and efficacy that resonates with its target audience of health-conscious consumers and trusted healthcare practitioners.

This strategy is particularly effective in building a premium brand. While many competitors focus on price, Thorne focuses on quality, purity, and scientific validation, justifying its higher price point. The company's long-standing reputation, bolstered by its NSF Certified for Sport® products and its vertically integrated manufacturing in South Carolina, is further enhanced by studies like these.

The announcement serves as a powerful marketing tool, providing tangible numbers that can be used in advertising, on product pages, and in communications with the thousands of health professionals who recommend the brand. In an industry where trust is a valuable currency, demonstrating a commitment to research—even if it's perception-based—can foster significant brand loyalty and provide a distinct competitive edge. As consumers continue to demand greater transparency and proven results, Thorne's data-driven approach may set a new standard, compelling other companies in the wellness space to follow their lead.